Applications of Animal Models of Infectious Arthritis in Drug Discovery: A focus on Alphaviral Disease

Lara Herrero, Michelle Nelson, Michelle Gahan, Suresh Mahalingham

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Animal models, which mimic human disease, are invaluable tools for understanding the mechanisms of disease pathogenesis and development of treatment strategies. In particular, animal models play important roles in the area of infectious arthritis. Alphaviruses, including Ross River virus (RRV), o'nyong-nyong virus, chikungunya virus (CHIKV), mayaro virus, Semliki Forest virus and sindbis virus, are globally distributed and cause transient illness characterized by fever, rash, myalgia, arthralgia and arthritis in humans. Severe forms of the disease result in chronic incapacitating arthralgia and arthritis. The mechanisms of how these viruses cause musculoskeletal disease are ill defined. In recent years, the use of a mouse model for RRV-induced disease has assisted in unraveling the pathobiology of infection and in discovering novel drugs to ameliorate disease. RRV as an infection model has the potential to provide key insights into such disease processes, particularly as many viruses, other than alphaviruses, are known to cause infectious arthritides. The emergence and outbreak of CHIKV in many parts of the world has necessitated the need to develop animal models of CHIKV disease. The development of non-human primate models of CHIKV disease has given insights into viral tropism and disease pathogenesis and facilitated the development of new treatment strategies. This review highlights the application of animal models of alphaviral diseases in the fundamental understanding of the mechanisms that contribute to disease and for defining the role that the immune response may have on disease pathogenesis, with the view of providing the foundation for new treatments.
Original languageEnglish
Pages (from-to)1024-1036
Number of pages13
JournalCurrent Drug Targets
Volume12
Issue number7
DOIs
Publication statusPublished - 2011

Fingerprint

Infectious Arthritis
Drug Discovery
Viruses
Chikungunya virus
Animals
Animal Models
Virus Diseases
Ross River virus
Alphavirus
Arthralgia
Arthritis
Viral Tropism
Musculoskeletal Diseases
Semliki forest virus
Sindbis Virus
Animal Disease Models
Rivers
Myalgia
Human Development
Exanthema

Cite this

Herrero, Lara ; Nelson, Michelle ; Gahan, Michelle ; Mahalingham, Suresh. / Applications of Animal Models of Infectious Arthritis in Drug Discovery: A focus on Alphaviral Disease. In: Current Drug Targets. 2011 ; Vol. 12, No. 7. pp. 1024-1036.
@article{800452195dce4b0caab0469b5d5eb37e,
title = "Applications of Animal Models of Infectious Arthritis in Drug Discovery: A focus on Alphaviral Disease",
abstract = "Animal models, which mimic human disease, are invaluable tools for understanding the mechanisms of disease pathogenesis and development of treatment strategies. In particular, animal models play important roles in the area of infectious arthritis. Alphaviruses, including Ross River virus (RRV), o'nyong-nyong virus, chikungunya virus (CHIKV), mayaro virus, Semliki Forest virus and sindbis virus, are globally distributed and cause transient illness characterized by fever, rash, myalgia, arthralgia and arthritis in humans. Severe forms of the disease result in chronic incapacitating arthralgia and arthritis. The mechanisms of how these viruses cause musculoskeletal disease are ill defined. In recent years, the use of a mouse model for RRV-induced disease has assisted in unraveling the pathobiology of infection and in discovering novel drugs to ameliorate disease. RRV as an infection model has the potential to provide key insights into such disease processes, particularly as many viruses, other than alphaviruses, are known to cause infectious arthritides. The emergence and outbreak of CHIKV in many parts of the world has necessitated the need to develop animal models of CHIKV disease. The development of non-human primate models of CHIKV disease has given insights into viral tropism and disease pathogenesis and facilitated the development of new treatment strategies. This review highlights the application of animal models of alphaviral diseases in the fundamental understanding of the mechanisms that contribute to disease and for defining the role that the immune response may have on disease pathogenesis, with the view of providing the foundation for new treatments.",
author = "Lara Herrero and Michelle Nelson and Michelle Gahan and Suresh Mahalingham",
year = "2011",
doi = "10.2174/138945011795677836",
language = "English",
volume = "12",
pages = "1024--1036",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

Applications of Animal Models of Infectious Arthritis in Drug Discovery: A focus on Alphaviral Disease. / Herrero, Lara; Nelson, Michelle; Gahan, Michelle; Mahalingham, Suresh.

In: Current Drug Targets, Vol. 12, No. 7, 2011, p. 1024-1036.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Applications of Animal Models of Infectious Arthritis in Drug Discovery: A focus on Alphaviral Disease

AU - Herrero, Lara

AU - Nelson, Michelle

AU - Gahan, Michelle

AU - Mahalingham, Suresh

PY - 2011

Y1 - 2011

N2 - Animal models, which mimic human disease, are invaluable tools for understanding the mechanisms of disease pathogenesis and development of treatment strategies. In particular, animal models play important roles in the area of infectious arthritis. Alphaviruses, including Ross River virus (RRV), o'nyong-nyong virus, chikungunya virus (CHIKV), mayaro virus, Semliki Forest virus and sindbis virus, are globally distributed and cause transient illness characterized by fever, rash, myalgia, arthralgia and arthritis in humans. Severe forms of the disease result in chronic incapacitating arthralgia and arthritis. The mechanisms of how these viruses cause musculoskeletal disease are ill defined. In recent years, the use of a mouse model for RRV-induced disease has assisted in unraveling the pathobiology of infection and in discovering novel drugs to ameliorate disease. RRV as an infection model has the potential to provide key insights into such disease processes, particularly as many viruses, other than alphaviruses, are known to cause infectious arthritides. The emergence and outbreak of CHIKV in many parts of the world has necessitated the need to develop animal models of CHIKV disease. The development of non-human primate models of CHIKV disease has given insights into viral tropism and disease pathogenesis and facilitated the development of new treatment strategies. This review highlights the application of animal models of alphaviral diseases in the fundamental understanding of the mechanisms that contribute to disease and for defining the role that the immune response may have on disease pathogenesis, with the view of providing the foundation for new treatments.

AB - Animal models, which mimic human disease, are invaluable tools for understanding the mechanisms of disease pathogenesis and development of treatment strategies. In particular, animal models play important roles in the area of infectious arthritis. Alphaviruses, including Ross River virus (RRV), o'nyong-nyong virus, chikungunya virus (CHIKV), mayaro virus, Semliki Forest virus and sindbis virus, are globally distributed and cause transient illness characterized by fever, rash, myalgia, arthralgia and arthritis in humans. Severe forms of the disease result in chronic incapacitating arthralgia and arthritis. The mechanisms of how these viruses cause musculoskeletal disease are ill defined. In recent years, the use of a mouse model for RRV-induced disease has assisted in unraveling the pathobiology of infection and in discovering novel drugs to ameliorate disease. RRV as an infection model has the potential to provide key insights into such disease processes, particularly as many viruses, other than alphaviruses, are known to cause infectious arthritides. The emergence and outbreak of CHIKV in many parts of the world has necessitated the need to develop animal models of CHIKV disease. The development of non-human primate models of CHIKV disease has given insights into viral tropism and disease pathogenesis and facilitated the development of new treatment strategies. This review highlights the application of animal models of alphaviral diseases in the fundamental understanding of the mechanisms that contribute to disease and for defining the role that the immune response may have on disease pathogenesis, with the view of providing the foundation for new treatments.

U2 - 10.2174/138945011795677836

DO - 10.2174/138945011795677836

M3 - Article

VL - 12

SP - 1024

EP - 1036

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 7

ER -